Evaluating the safety and effectiveness of transcatheter aortic valves in Chinese patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to collect clinical baseline, procedural, and follow-up data from patients treated with transcatheter aortic valve replacement (TAVR) across multiple centers in China. The study will evaluate short-, mid-, and long-term clinical outcomes of post-marketing transcatheter valves, addressing a significant gap in knowledge regarding TAVR efficacy and safety in the Chinese population. With a focus on elderly patients suffering from aortic stenosis, the study will track outcomes for up to 10 years to provide valuable insights into this treatment option. The findings will help validate TAVR's use in a population that has not been extensively studied before.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients with aortic valve disease are evaluated by the cardiac team and indicate TAVR therapy
2. Patients who understand the purpose of this study, voluntarily participate in the trial and sign the informed consent form

Exclusion Criteria:

1. Patients with aortic valve disease who have been evaluated by a cardiac team as unsuitable for TAVR
2. Patients who cannot tolerate the materials or medications associated with this study
3. Women who are pregnant or breastfeeding
4. Patients who participated in a clinical trial of another drug or medical device before enrollment

Where it's running

• Ling Tao
  Xi'an, Shaanxi, China Recruiting

Study contacts

• Study coordinator: Rutao Wang, M.D, Ph.D
• Email: rutaowang@qq.com
• Phone: +86-15091095796

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating outcomes in patients with moderate mixed aortic valve disease

  This study is trying to see if patients with moderate mixed aortic valve disease have different death rates compared to those with severe aortic stenosis or regurgitation, and if they might benefit from treatment even if they don’t have severe symptoms.

  Recruiting Leiden University Medical Center · Leiden, South Holland · NCT06789211

• Investigating multiple and mixed heart valve diseases

  This study looks at how common different types of heart valve diseases are and their features by gathering information from patients around the world who have been diagnosed with these conditions.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris, Île-de-France Region · NCT06235385

• KONECT RESILIA Aortic Valved Conduit real-world use in adults needing valve and ascending aorta replacement

  This study tests how the KONECT RESILIA aortic valved conduit performs in adults needing aortic valve and ascending aorta replacement.

  Recruiting at 3 sites Edwards Lifesciences · München, Bavaria and 2 other locations · NCT07619872

• Savvywire versus standard LV guidewires during transfemoral TAVI

  For people 50 and older having transfemoral TAVI, researchers will compare the Savvywire and standard LV guidewires to see if the Savvywire improves pacing and procedure-related blood flow.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07366671

• EmStop Embolic Protection System for TAVR in Aortic Valve Stenosis

  This study tests whether the EmStop protective device can safely capture and remove debris during transcatheter aortic valve replacement in adults with severe aortic valve stenosis.

  Recruiting at 7 sites EmStop Inc · Thousand Oaks, California and 6 other locations · NCT07276711

• Tracking progression and consequences of heart valve disease

  This project will follow adults with moderate or worse valve disease to see if clinical tests and imaging can predict when their condition will get worse.

  Recruiting at 15 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Fuzhou, Fujian and 14 other locations · NCT07267117

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.